Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

24 Oct 2014 07:00

RNS Number : 1620V
4imprint Group PLC
24 October 2014
 

 

4imprint Group plc

Interim Management Statement 24 October 2014

 

4imprint Group plc (the "Group"), the leading international direct marketer of promotional products, today issues its Interim Management Statement for the period from 29 June 2014 to 23 October 2014, incorporating information relating to the financial performance of the Group for its third quarter, being the period from 29 June 2014 to 27 September 2014, and the year to date (nine months) compared with the equivalent periods last year.

 

The Group continues to report strong organic growth. Revenue* for the third quarter was £66.13m, 16% ahead of last year. Year to date revenue* was £181.79m, 15% ahead of last year. The average year to date USD exchange rate was 1.67 (2013:1.55).

 

North American revenue* in US dollars for the third quarter was $106.14m, 25% ahead. Year to date revenue* was $291.24m, 24% ahead.

 

As in the first half, the growth was driven by the rate of increase in marketing spend compared to last year, capitalising on recent opportunities for enhanced online marketing. The number of orders received from existing customers compared to last year increased by 25% in the third quarter and by 22% year to date. Orders from new customers compared to last year also increased by 25% in the third quarter and by 22% year to date.

 

The UK Direct Marketing business achieved third quarter revenue* growth of 27%, with year to date revenue* at £7.39m, 23% ahead.

 

Financial position

On 17 September 2014, the Group announced that the Trustee of the 4imprint Group Pension Scheme had completed a pension buy-in transaction and a Company contribution of £13.73m was paid to the Scheme at that date. The buy-in is in line with the established strategy of reducing the risk of the Group's legacy pension scheme. Approximately 76% of the Scheme's total liabilities are now insured.

 

At the end of the third quarter the Group had net cash of £7.82m, compared to £26.13m reported at 28 June 2014, following the pension contribution above and regular second half outflows.

 

Change in presentational currency

The Board has decided to present the Group's financial statements in US dollars with effect from the 2014 year end results announcement due to be reported in March 2015. A substantial proportion of the Group's revenue and earnings originate in US dollars and the change will therefore more closely align external reporting with the profile of the Group. In future, dividends will be determined in US dollars and paid in Sterling at the exchange rate at the time the dividend is determined. More information, including restated H1 2014 and FY 2013 figures will be provided in an RNS in November.

 

 

Outlook

The Group has continued to achieve strong revenue growth, leaving it ahead of management expectations at this stage in the year and underpinning the Board's expectation that the Group will achieve a good result for the year as a whole.

 

*Revenue now includes delivery receipts and excludes discontinued operations. Prior periods have been restated for the impact of these items.

  

 

For further information, please contact:

4imprint Group plc

MHP Communications

Tel: + 44 (0) 20 7299 7201

John Poulter

Chairman

 

Gillian Davies

Group Finance Director

Reg Hoare

Tel: + 44 (0) 20 3128 8793

 

Katie Hunt

Tel: + 44 (0) 20 3128 8794

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSBDGXXDBGSX
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.